Did you see this? A review of public comments on a proposed FDA regulatory framework for modifications to #AI and #machinelearning based software as a medical device has found that 63% came from parties with financial ties to industry. http://ow.ly/hAWE50C5cIu https://t.co/aFTQHYcLAh
NEW PRINT on @medrxivpreprint (led by @JamesASmith92) Financial interests and evidence in public comments on the #FDA framework for modifications to #ArtificialIntelligence / #MachineLearning learning-based #Medicaldevices https://www.medrxiv.org/content/10.1101/2019.12.11.19013953v1 @ndorms @OxfordBRC @CSMOxford
FDA has been requesting feedback on their proposed AI/ML Software-as-Medical-Device (SaMD) framework, and our comments (@BpGenetics) were just published. Check out the thread below! #SaMD #AI #MachineLearning #healthcare https://t.co/ldvn3htE3h
